Biotech and Pharmaceuticals

Trump’s Bold Move: Upcoming 200% Tariff on Pharmaceuticals Could Impact Your Wallet!
President Donald Trump has recently announced plans to impose tariffs of up to 200% on pharmaceuticals imported into the U.S. ... Read more

Exciting Breakthrough: Moderna’s Flu Vaccine Shines in Late-Stage Trials, Setting the Stage for a Combined COVID Vaccine
Moderna recently revealed that its new mRNA-based flu vaccine is showing promise. In late-stage trials, it triggered a stronger immune ... Read more

UnitedHealth Group Stock Dips 18% Amid DOJ Investigation into Alleged Medicare Fraud: What You Need to Know
Shares of UnitedHealth Group dropped over 18% on Thursday after reports emerged that the Department of Justice (DOJ) is investigating ... Read more

Breaking News: UnitedHealth Group CEO Andrew Witty Resigns as Company Suspends Annual Forecast—What It Means for the Future
UnitedHealth Group recently made headlines with the sudden exit of its CEO, Andrew Witty. His departure surprised many and sent ... Read more

Novo Nordisk Shares Surge 7% Amid Predictions of Easing Wegovy Rivalry in 2025
Novo Nordisk recently saw its shares jump nearly 7%. Why? They reported that sales of Wegovy, their weight-loss drug, are ... Read more

Eli Lilly’s Sales Skyrocket 45% Thanks to Weight Loss Drug Demand, Yet Profit Forecast Dips Following Cancer Treatment Acquisition
Eli Lilly recently shared its financial results for the first quarter, highlighting increasing demand for its weight loss and diabetes ... Read more

Novo Nordisk Expands Wegovy Weight Loss Drug Access via Telehealth: Hims & Hers Shares Surge 30%!
Novo Nordisk Expands Wegovy Access through Telehealth Partnerships Novo Nordisk has announced an exciting development for those seeking weight loss ... Read more

Pfizer Halts Weight Loss Pill Development Following Liver Injury Report: What This Means for Your Health
Pfizer recently announced it will stop developing its daily weight loss pill, danuglipron, due to a patient experiencing potentially harmful ... Read more

Revolutionary Novo Nordisk Diabetes Pill Reduces Cardiovascular Risk by 14% in Just Four Years!
Novo Nordisk recently announced exciting news about Rybelsus, its diabetes pill. In a late-stage trial, Rybelsus showed significant cardiovascular benefits ... Read more